IRIS Institutional Research Information System - OPENBS Open Archive UniBS

PIZZI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.089
EU - Europa 7.900
AS - Asia 6.422
SA - Sud America 1.049
Continente sconosciuto - Info sul continente non disponibili 594
AF - Africa 140
OC - Oceania 19
AN - Antartide 1
Totale 28.214
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.849
PL - Polonia 3.264
CN - Cina 2.144
SG - Singapore 2.018
UA - Ucraina 1.056
IT - Italia 899
BR - Brasile 855
DE - Germania 775
HK - Hong Kong 635
VN - Vietnam 507
FI - Finlandia 422
GB - Regno Unito 379
FR - Francia 359
IN - India 330
RU - Federazione Russa 244
TR - Turchia 208
BD - Bangladesh 194
IE - Irlanda 183
CA - Canada 129
ID - Indonesia 69
AR - Argentina 61
MX - Messico 59
NL - Olanda 59
JP - Giappone 50
IQ - Iraq 48
SE - Svezia 46
BE - Belgio 44
ZA - Sudafrica 44
ES - Italia 41
KR - Corea 35
CZ - Repubblica Ceca 31
EC - Ecuador 28
PK - Pakistan 28
AT - Austria 27
CO - Colombia 25
UZ - Uzbekistan 23
VE - Venezuela 21
CL - Cile 20
KE - Kenya 18
MA - Marocco 18
IR - Iran 17
AU - Australia 16
EU - Europa 16
IL - Israele 16
NG - Nigeria 13
JM - Giamaica 12
PE - Perù 12
SA - Arabia Saudita 12
JO - Giordania 11
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
TN - Tunisia 10
AZ - Azerbaigian 9
UY - Uruguay 9
CH - Svizzera 8
ET - Etiopia 8
LT - Lituania 8
OM - Oman 8
PH - Filippine 8
CR - Costa Rica 7
DZ - Algeria 7
HN - Honduras 7
BO - Bolivia 6
EG - Egitto 6
MU - Mauritius 6
RO - Romania 6
AL - Albania 5
LV - Lettonia 5
NP - Nepal 5
BG - Bulgaria 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
KZ - Kazakistan 4
LK - Sri Lanka 4
SK - Slovacchia (Repubblica Slovacca) 4
SN - Senegal 4
SV - El Salvador 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
EE - Estonia 3
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
MD - Moldavia 3
MY - Malesia 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PA - Panama 3
PT - Portogallo 3
AM - Armenia 2
BH - Bahrain 2
BY - Bielorussia 2
CY - Cipro 2
GR - Grecia 2
KW - Kuwait 2
LB - Libano 2
PS - Palestinian Territory 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
Totale 27.611
Salva come PNG Salva come JPEG
Città #
Warsaw 3.258
Singapore 1.055
Fairfield 1.040
Ashburn 1.028
Woodbridge 812
Jacksonville 732
Hong Kong 629
Houston 625
Ann Arbor 493
Chandler 474
Beijing 446
Cambridge 441
San Jose 434
Seattle 414
Wilmington 387
The Dalles 341
Princeton 316
New York 312
Nanjing 298
Brescia 286
Los Angeles 267
Council Bluffs 259
Helsinki 256
Dearborn 206
Dallas 201
Dublin 182
Lauterbourg 171
Istanbul 166
Columbus 149
Dong Ket 126
Ho Chi Minh City 117
Munich 111
Milan 106
Buffalo 103
Des Moines 102
Chicago 100
Nanchang 90
San Francisco 87
Pune 84
Hanoi 81
Santa Clara 81
São Paulo 81
Shenyang 80
Moscow 74
Shanghai 72
Hebei 71
Jinan 69
Tianjin 69
Redondo Beach 68
Lancaster 65
Changsha 62
Orem 58
London 56
Phoenix 53
San Diego 52
Jakarta 49
Montreal 42
Brussels 41
Denver 38
Chennai 36
Brooklyn 35
Toronto 35
Turku 35
Guangzhou 33
Rome 33
Kunming 32
Jiaxing 31
Hangzhou 30
Salt Lake City 30
Tokyo 30
Ningbo 29
Zhengzhou 29
Amsterdam 27
Atlanta 26
Rio de Janeiro 26
Nuremberg 25
Baghdad 22
Frankfurt am Main 22
Lanzhou 22
Taizhou 22
Tashkent 22
Verona 22
Brasília 21
Johannesburg 21
Manassas 21
Manchester 21
Boardman 20
Boston 20
Mexico City 20
Norwalk 20
Stockholm 20
Brno 19
Tampa 19
Belo Horizonte 18
Mumbai 18
Orange 18
Poplar 18
Porto Alegre 18
Haikou 17
Nairobi 17
Totale 18.966
Salva come PNG Salva come JPEG
Nome #
CHF5074 (CSP-1103) induces microglia alternative activation in plaque-free Tg2576 mice and primary glial cultures exposed to beta-amyloid 377
Neuroprotective and Anti-Apoptotic Effects of CSP-1103 in Primary Cortical Neurons Exposed to Oxygen and Glucose Deprivation 366
Plasma NfL, GFAP, amyloid, and p-tau species as Prognostic biomarkers in Parkinson’s disease 353
Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation 344
PEA and luteolin synergistically reduce mast cell-mediated toxicity and elicit neuroprotection in cell-based models of brain ischemia 333
Targeted acetylation of NF-kappaB/RelA and histones by epigenetic drugs reduces post-ischemic brain injury in mice with an extended therapeutic window. 331
1B/(-)IRE DMT1 Expression during Brain Ischemia Contributes to Cell Death Mediated by NF-κB/RelA Acetylation at Lys310 323
Glutamatergic reinnervation through peripheral nerve graft dictates assembly of glutamatergic synapses at rat skeletal muscle 321
Glutamatergic Reinnervation and Assembly of Glutamatergic Synapses in Adult Rat Skeletal Muscle Occurs at Cholinergic Endplates 320
Glutamatergic neurons induce expression of functional glutamatergic synapses in primary myotubes. 320
Priming of cultured neurons with sabeluzole results in long-lasting inhibition of neurotoxin-induced tau expression and cell death. 309
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 306
A Polyphenol-Enriched Supplement Exerts Potent Epigenetic-Protective Activity in a Cell-Based Model of Brain Ischemia 304
NF-κB and epigenetic mechanisms as integrative regulators of brain resilience to anoxic stress. 302
NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases 292
Late-onset Parkinsonism in NFκB/c-Rel-deficient mice. 282
Acetylation state of RelA modulated by epigenetic drugs prolongs survival and induces a neuroprotective effect on ALS murine model 281
1,2,4-Triazine derivatives as agents for the prevention of AGE-RAGE-mediated inflammatory cascade in THP-1 monocytes: An approach to prevent inflammation-induced late diabetic complications 272
Mild inflammatory profile without gliosis in the c-rel deficient mouse modeling a late-onset parkinsonism 271
The End Is the Beginning: Parkinson's Disease in the Light of Brain Imaging 268
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke 266
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 263
Pharmacological targeting of the beta-amyloid precursor protein intracellular domain 245
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 225
NUOVO IMPIEGO TERAPEUTICO PREVENTIVO DELLA SUBUNITA' C-REL DELLA PROTEINA NF-KAPPAB E NUOVO IMPIEGO DI UN ANIMALE TRASGENICO NON UMANO CHE PORTA LA DELEZIONE DEL GENE C-REL (C-REL-/-) 221
Mitochondria and alpha-synuclein: Friends or foes in the pathogenesis of Parkinson's disease? 210
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 209
NF-κB/c-Rel deficiency causes Parkinson's disease-like prodromal symptoms and progressive pathology in mice 208
The gamma-Secretase Modulator CHF5074 Reduces the Accumulation of Native Hyperphosphorylated Tau in a Transgenic Mouse Model of Alzheimer's Disease 207
The Role of Mast Cells in Stroke 207
Chapter 24 NF-KappaB Dimers in the Regulation of Neuronal Survival 206
Post-ischemic brain damage: NF-kappaB dimer heterogeneity as a molecular determinant of neuron vulnerability 204
NF-kappaB p50/RelA and c-Rel-containing dimers: opposite regulators of neuron vulnerability to ischaemia. 204
Bim and Noxa are candidates to mediate the deleterious effect of the NF-kappa B subunit RelA in cerebral ischemia. 202
The gamma-secretase modulator CHF5074 elicits neuroprotection and increases histone acetylation in primary cortical neurons exposed to oxygen glucose deprivation 202
Raman Probes for in Situ Molecular Analyses of Peripheral Nerve Myelination 202
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 200
c-Rel deficient mice, a mouse model of "spreading" PD-like pathology. 199
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 195
Targeting IKK2 by pharmacological inhibitor AS602868 prevents excitotoxic injury to neurons and oligodendrocytes. 194
Spinal cord mGlu1a receptors - Possible target for amyotrophic lateral sclerosis therapy 193
Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. 192
Activation of dopamine D2 receptors linked to voltage-sensitive potassium channels reduces forskolin-induced cyclic AMP formation in rat pituitary cells. 185
Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line 184
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 178
Activation of multiple metabotropic glutamate receptor subtypes prevents NMDA-induced excitotoxicity in rat hippocampal slices. 178
Risk and protective factors associated with mental health status in an Italian sample of students during the fourth wave of COVID-19 pandemic 177
A Tau antisense oligonucleotide decreases neurone sensitivity to excitotoxic injury. 177
Differential pattern of expression of G proteins in nucleus striatum from 6-hydroxydopamine lesioned rats. 176
EXACERBATED AGE-DEPENDENT LOSS OF NIGRAL DOPAMINERGIC NEURONS IN NF-KAPPAB C-REL -/- MICE 174
c-Rel deficient mice, a mouse model of “spreading” PD-like pathology 172
Electrophysiological and metabolic effects of CHF5074 in the hippocampus: protection against in vitro ischemia. 169
Synapsin III alterations in Parkinson's disease 168
Activation of NF-kappaB p65/c-Rel dimer is associated with neuroprotection elicited by mGlu5 receptor agonists against MPP(+) toxicity in SK-N-SH cells. 168
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 166
N-methyl-D-aspartate neurotoxicity in hippocampal slices: protection by aniracetam. 164
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 162
Synergistic association of valproate and resveratrol reduces brain injury in ischemic stroke. 162
Degenerazione età –dipendente dei neuroni dopaminergici della sostanza nera nei topi NF-kappaB cRel 159
Acetylation of NF-kappaB p50/RelA and histones in the epigenetic regulation of pro-apoptotic transcription: a neuroprotective target in brain ischemia 157
A bioinformatics analysis of memory consolidation reveals involvement of the transcription factor c-rel. 154
SYNERGIC ROLE OF RESVERATROL AND HDACi MS-275 IN NEUROPROTECTION 154
Cortical neurons induce the expression of glutamate receptors in primary myotubes 154
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 154
Inhibition of glutamate-induced neurotoxicity by a tau antisense oligonucleotide in primary culture of rat cerebellar granule cells 150
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of Parkinson’s disease and dementia with Lewy bodies, 150
Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices. 147
Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. 146
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 146
An in vitro method of diagnosing Parkinson's disease 146
Synapsin III Alteration in Parkinson's disease 146
Inhibition of IκBα phosphorylation prevents glutamate-induced NF-κB activation and neuronal cell death 145
Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. 143
Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro 143
AAV-mediated overexpression of alpha-synuclein in midbrain dopamine neurons of Synapsin III knockout mice reveals novel molecular features involved in Parkinson's disease pathology. 143
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 143
Pharmacological basis for dopamine D-2 receptor diversity 142
Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats 142
Involvement of Synapsin III in the onset of Alpha-synuclein pathology in Parkinson’s Disease 142
Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. 142
CHF5074, a novel gamma-secretase modulator, attenuates brain beta-amyloid pathology and learning deficit in a mouse model of Alzheimer's disease. 141
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 141
A soluble interleukin-6 (IL6) recepetor/IL6 fusion protein enhances the in vitro differentiation of purified rat oligodendroglial lineage cells 141
Alpha-Synuclein in the Regulation of Brain Endothelial and Perivascular Cells: Gaps and Future Perspectives 141
Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. 140
From preclinical stroke models to humans: Polyphenols in the prevention and treatment of stroke 139
DIVALENT METAL TRANSPORTER 1-DEPENDENT ISCHEMIC NEURODEGENERATION: STRATEGIES TO KNOCKDOWN FERROUS IRON UPTAKE 138
Synapsin III Alteration in Parkinson's disease 138
NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production 137
Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation 136
Lack of vasoactive intestinal peptide-releasing property in prolactin cells from ovariectomized rats: contribution of post-transductional impairments 136
Blockade of the tumor necrosis factor-related apoptosis inducing ligand death receptor DR5 prevents beta-amyloid neurotoxicity. 134
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 134
Spinal cord mGlu1a receptors: possible target for amyotrophic lateral sclerosis therapy. 134
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 133
The acetylation of RelA in Lys310 dictates the NF-κB-dependent response in post-ischemic injury. 132
An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disorders 132
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 131
The interplay among nonsuicidal self-injury, depression, loneliness, resilience, and family relationships in youth: A path analysis 130
The inhibitor of IkappaBalpha phosphorylation BAY 11-7082 prevents NMDA neurotoxicity in mouse hippocampal slices. 130
Totale 19.655
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.874
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.874
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.275 0 272 25 37 25 64 87 77 70 181 129 308
2022/20231.311 187 34 56 102 134 329 3 132 192 27 58 57
2023/20241.384 92 34 120 82 68 325 55 66 276 31 33 202
2024/20253.480 24 44 34 408 344 208 335 122 513 164 864 420
2025/20267.405 707 896 551 1.048 745 566 1.068 331 435 576 334 148
2026/2027667 435 232 0 0 0 0 0 0 0 0 0 0
Totale 28.214